Discover 1,944 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,944
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
for
Difficult to Control Hypertension
Location: Mansfield TX, Dallas TX, Plano TX, Denton TX,
Sponsor: E-Star BioTech, LLC
Sex: All
Age: 18 - 70+
Code: NCT06343298
Phase 2, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Mansfield TX, Fort Worth TX, Dallas TX,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase 3, Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Mansfield TX, Fort Worth TX, Dallas TX, Sherman TX,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase 2, Phase 3, Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
for
Inflammatory Bowel Diseases, Crohn's Disease
Location: Mansfield TX, Lewisville TX, Tyler TX, Cedar Park TX,
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Sex: All
Age: 18 - 70+
Code: NCT06226883
Phase 2, Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis (UC), Severe Ulcerative Colitis,
Location: Fort Worth TX, Dallas TX, Boston MA, Rochester MN,
Sponsor: Direct Biologics, LLC
Sex: All
Age: 18 - 70+
Code: NCT05354141
Phase 3, Recruiting
A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)
for
Liver Diseases, Alcoholic
Location: Fort Worth TX, San Antonio TX, Topeka KS, Chandler AZ,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07791043
Phase 2, Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency (GHD)
Location: Fort Worth TX, New Brunswick NJ, San Antonio TX,
Sponsor: Lumos Pharma
Sex: All
Age: 3 - 11
Code: NCT06948214
Phase 3, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Fort Worth TX, Nashville TN, Chattanooga TN,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05714839
Phase 1, Phase 2, Recruiting
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
for
Neoplasms, Lung
Location: Fort Worth TX, Hinsdale IL, Canton OH, Tamarac FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07099898
Phase 3, Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
for
Hypoxic-Ischemic Encephalopathy
Location: Fort Worth TX, Houston TX, Little Rock AR, St Louis MO,
Sponsor: ReAlta Life Sciences, Inc.
Sex: All
Age: 0
Code: NCT05778188
Phase 2, Phase 3, Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
for
Neoplasms, Head and Neck
Location: Fort Worth TX, Dallas TX, San Antonio TX, Tulsa OK,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06256588
Phase 3, Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: Mansfield TX, Grapevine TX, Fort Worth TX, Mesquite TX,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 16+
Code: NCT06617325
Phase 3, Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis